JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Support: [email protected]

Track Your Order

PLK

C5813 CFI-400945

Summary: orally available, selective inhibitor of polo-like kinase 4 (PLK4)

insoluble in H2O; ≥109.8 mg/mL
C3340 3MB-PP1

Summary: polo-like kinase 1 (Plk1) allele inhibitor,ATP-competitive

≤2 mg/mL
B7279 Cyclapolin 9

Summary: PLK1 inhibitor

<7.68 mg/mL
B5860 TAK960

Target: PLK

Summary: Oral and selective PLK1 inhibitor

≥28.05 mg/mL
B5857 SBE 13 HCl

Target: PLK

Summary: Inactive Plk1 inhibitor

Soluble in DMSO
B5604 TC-S 7005

Summary: polo-like kinase 2 (PLK2) inhibitor

<35.94 mg/mL
B4094 NMS-1286937

Target: PLK

Summary: PLK1 inhibitor, orally bioavailable

insoluble in H2O; insoluble in EtOH; ≥13.33 mg/mL
B3609 Poloxime

Summary: polo-like kinase 1 （PLK) analogue

Soluble in DMSO
B1288 Rigosertib

Target: PI3K|PLK

Summary: PI3K/PLK1 inhibitor

Soluble in DMSO
A8681 Ro3280

Target: PLK

Summary: PLK1 inhibitor,potent and highly selective

≥27.2 mg/mL